Efficacy of daratumamab in combination with pomalidomide and dexamethasone in relapsed/refractory myeloma patients
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Daratumumab (Primary) ; Dexamethasone (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 Dec 2017 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology